靶向治疗时代下的非小细胞肺癌化疗现状与进展(5)
[15] Ettinger DS， Akerley W， Borghaei H， et al. Non-small cell lung cancer， version 2. 2013 [J]. J Natl Compr Canc Netw， 2013， 11(6)： 645-653.[16] Yoshimura N， Okishio K， Mitsuoka S， et al. Prospective assessment of continuation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of pemetrexed [J]. J Thorac Oncol ......
您现在查看是摘要页，全文长 3044 字符。